🔓
Sign in as a Member to unlock the full view of S.708. · Full carveout list, all affected companies, party defectors, and 30-day trade predictions.
Become a Member$24.50/mo already a Member? Sign in →
S.708 · 118TH CONGRESS

A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.

Status
Dead
Official Source
Investability
46/100
Stage
COMMITTEE
Related Bills
0
Full Text
1,507 chars
Alive
No

What This Bill Does · Plain English

Summary
Plain-English summary not yet available for this bill. Check back after our next analysis run.

Frequently Asked Questions

Did S.708 pass?
S.708 did not pass and is no longer active. Final stage: COMMITTEE.

Full Bill Text

118 S708 IS: To improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions. U.S. Senate 2023-03-08 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. II 118th CONGRESS 1st Session S. 708 IN THE SENATE OF THE UNITED STATES March 8, 2023 Mr. Brown (for himself and Mr. Scott of South Carolina ) introduced the following bill; which was read twice and referred to the Committee on Finance A BILL To improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions. 1. Guidance relating to Medicaid coverage of genetic testing to improve outcomes for beneficiaries with major depressive disorder or other mental health conditions Not later than 1 year after the date of enactment of this Act, the Administrator of the Centers for Medicare & Medicaid Services shall issue guidance for State Medicaid programs through a State Medicaid Director letter that specifies best practices to improve outcomes for individuals eligible for medical assistance under State Medicaid programs who have major depressive disorder or other mental health conditions. The guidance shall include coverage policy examples utilizing pharmacogenetic testing to support clinicians seeking medication options to treat patients and reduce trial and error from the Medicare program or from issuers of individual or group health insurance coverage.
🔒 GovGreed Pro · Trading Intelligence on S.708 Get Access — $24.50/mo
Loading intelligence layer…
Bill text sourced from GovInfo.gov · public domain · last updated 2026-05-18. Plain-English summary, score breakdown, and trading-intelligence panels are GovGreed-original analysis derived from STOCK Act filings, SEC Form 4 disclosures, FEC contributions, and Senate LDA lobbying reports — all publicly filed federal records. GovGreed is not affiliated with the U.S. Government. Not financial advice. [live render]